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Background: Antimicrobial growth promoters (AGPs) are antimicrobial agents administered to livestock in feed for
prolonged periods to enhance feed efficiency. Beef cattle are primarily finished in confined feeding operations in
Canada and the USA, and the administration of AGPs such as chlortetracycline and sulfamethazine (Aureo S-700 G)
is the standard. The impacts of AGPs on the intestinal microbiota of beef cattle are currently uncertain; it is
documented that AGPs administered to beef cattle pass through the rumen and enter the intestine. To ascertain
the impacts of Aureo S-700 G on the small and large intestinal microbiota of beef cattle (mucosa-associated and
within digesta), terminal restriction fragment length polymorphism (T-RFLP) analysis and quantitative PCR (qPCR) for
total bacteria were applied. Beef cattle were maintained in an experimental feedlot (five replicate pens per
treatment), and AGP treatment cattle were administered Aureo S-700 G in feed, whereas control cattle were
administered no antimicrobials. As the intestinal microbiota of beef cattle has not been extensively examined, clone
library analysis was applied to ascertain the primary bacterial constituents of the intestinal microbiota.
Results: Comparative T-RFLP and qPCR analysis (n = 122 samples) revealed that bacterial community fingerprints
and bacterial load within digesta differed from those associated with mucosa. However, the administration of Aureo
S-700 G did not affect bacterial community fingerprints or bacterial load within the small and large intestine relative
to control cattle. Analysis of >1500 near full length 16S rDNA clones revealed considerably greater bacterial diversity
in the large relative to the small intestine of beef cattle. Mucosa-associated bacterial communities in the jejunum
were dominated by Proteobacteria, and differed conspicuously from those in the ileum and large intestine.
Although the ileum contained bacterial clones that were common to the jejunum as well as the cecum, Firmicutes
clones associated with mucosa dominated in the ileum, cecum, and descending colon. In the descending colon,
clone library analysis did not reveal a difference in the richness or diversity of bacterial communities within digesta
relative to those associated with mucosa. However, T-RFLP analysis indicated a significant difference in T-RF relative
abundance (i.e. difference in relative taxon abundance) between mucosa-associated and digesta communities
attributed in part to the differential abundance of Bacteriodes, Alistipes, Oscillibacter, and unclassified Clostridiales.
Conclusions: These data demonstrate that there was no significant difference in the composition of the
predominant intestinal bacteria constituents within animals administered Aureo S-700 G and those not
administered AGPs after a 28 day withdrawal period.
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Figure 1 Bovine intestine recreated from Nickel et al. [14]. Black
circles indicate mucosal locations sampled and processed, and outlined
circles indicate locations where digesta was sampled and processed in
addition to mucosa. Sample locations were: (1) descending portion of
the duodenum; (2) proximal jejunum; (3) central jejunum; (4) distal
jejunum; (5) ileum; (6) free end of the cecum; (7) central flexure of the
ascending colon; (8) descending colon; and (9) rectum.
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Antimicrobial growth promoters (AGPs) are commonly
administered in non-therapeutic concentrations in/on the
livestock feed to increase animal weight gain per unit of
feed consumed. Concerns over the development of anti-
microbial resistance (AMR) and the potential transmission
of resistant zoonotic pathogens to humans have become
prominent societal issues, and have resulted in a ban on
AGP use within the European Union (EU) [1,2]. The AGP
ban within the EU has concurrently increased the use of
therapeutically administered antimicrobials [1] and the
cost of animal production [3]. A recent guidance docu-
ment issued by the United States Food and Drug Admin-
istration recommended restrictions that will limit the use
of AGPs [4]. Thus, it is anticipated that an AGP ban will
progressively be imposed in North America.
The impending loss of AGPs in North America has pre-
cipitated a renewed interest in identifying efficacious alter-
natives to AGPs. However, a current lack of knowledge on
the mechanisms by which AGPs function has hampered
the development of alternatives. The literature on the
mode of action of AGPs is scarce; however, the most
widely accepted hypothesis is that AGPs modulate the
intestinal microbiota [5,6]. The ‘microbiota modulation’
hypothesis suggests that AGPs reduce microbial competi-
tion for nutrients, decrease production of growth depress-
ing metabolites by intestinal microorganisms, suppress
opportunistic pathogens, and result in a thinner intestinal
wall, which increases nutrient assimilation [5]. The
consistency of growth promotion effects imparted by
AGPs on various animal species possessing highly dissimi-
lar intestinal microbiota, coupled with the low concentra-
tions at which AGPs are administered (i.e. at doses less
than the minimum inhibitory concentration for most
pathogens) questions the validity of the microbiota modu-
lation hypothesis of AGP action [7]. Furthermore, the high
prevalence of carriage of antimicrobial resistance determi-
nants by livestock in the absence of selection pressure [8]
is not consistent with the microbiota modulation hypoth-
esis. Many antimicrobials have anti-inflammatory and
immunomodulatory properties [9], and we have recently
shown that the administration of chlortetracycline admin-
istered at non-therapeutic concentrations modulated the
enteric immune response, suggesting that AGPs may
function by suppressing inflammatory responses within
the intestine thereby providing a catabolic advantage to
the host (i.e. the ‘immunodulation’ hypothesis for AGP
action) [10].
Beef cattle are a significant livestock species produced in
North America, and the administration of AGPs to beef
cattle in confined feeding operations (i.e. feedlots) is the
industry standard [11]. AGPs administered to cattle pass
through the rumen into the intestine, and are excreted
in feces [12,13]. Yet characterization of the intestinalmicrobiota of cattle, including the impacts of AGPs on
the microbiota has received very limited attention.
Consistent with the immunomodulation hypothesis of
AGP action [10], we erected the hypothesis that AGPs
administered to beef cattle will not affect the intestinal
microbiota. Using animals maintained in an experimen-
tal feedlot, the study objectives were to characterize the
intestinal microbiota of cattle, and statistically contrast
bacterial community fingerprints and loads in the small
and large intestine of cattle administered Aureo
S-700 G relative to animals not administered an AGP.
Results
T-RFLP community analysis
Mucosal samples from nine intestinal locations of ten
steers (i.e. 90 samples), and digesta samples from the
central jejunum, ileum, cecum, and descending colon
were processed (Figure 1). It was not possible to obtain
adequate digesta from all animals at all intestinal loca-
tions; however, 32 digesta samples (out of a possible 40)
were processed. Digesta samples were obtained from the
central jejunum and ileum of three control treatment
cattle, from the ileum of three AS700 treatment cattle,
and from the cecum and descending colon of four
AS700 treatment cattle.
Diverse bacterial communities were observed in asso-
ciation with the intestinal mucosa and digesta at all nine
intestinal locations. Total numbers of T-RFs by sample
location ranged from 96 to 303 (Table 1). For both
Table 1 Mean terminal restriction fragment (T-RF)
number for digesta and mucosal samples obtained from
beef cattle administered (AS700) or not administered
antimicrobial growth promoters (Control)a
Sample/location AS700 Control LSDb Totalc
Digesta
Central jejunum 57.2 ± 2.4d 45.3 ± 8.6 a 153
Ileum 78.5 ± 10.5 52.3 ± 8.5 ab 254
Cecum 89.0 ± 7.7 80.2 ± 8.1 d 303
Descending colon 67.3 ± 3.9 68.4 ± 5.2 bc 247
Duodenum 51.8 ± 6.4 53.2 ± 11.2 ab 96
Proximal jejunum 55.6 ± 7.0 58.0 ± 5.2 abc 166
Central jejunum 57.4 ± 8.4 46.2 ± 8.2 a 156
Distal jejunum 46.6 ± 10.7 52.6 ± 6.3 a 181
Ileum 60.6 ± 13.6 54.8 ± 8.5 abc 142
Cecum 79.6 ± 10.7 79.4 ± 12.1 d 216
Spiral colon 57.6 ± 7.3 67.4 ± 17.9 abcd 195
Descending colon 60.6 ± 13.2 87.4 ± 6.9 cd 267
Rectum 62.8 ± 7.9 80.8 ± 10.4 bcd 236
a All samples consisted of five replicate cattle per treatment, with the
exception of digesta from the central jejunum of treatment cattle (n = 3), from
the ileum of control and AS700 treatment cattle (n = 3), and from the cecum
and descending colon of AS700 treated cattle (n = 4).
b Within each sample type (i.e. digesta or mucosa), locations (averaged over
treatment) not followed by the same letter differ (P ≤ 0.05) as determined by
Fisher's least significant difference (LSD).
c Total unique T-RFs (all animals combined by location and sample type).
d Values represent the mean ± the standard error of the mean.
Table 2 Group significance pairwise comparisons of T-RFLP
bacterial community fingerprints associated with mucosa
or within digesta between beef cattle administered
(AS700) or not administered antimicrobial growth
promoters (Control)a
Treatment/location T-RF presence/
absence
T-RF relative
abundance
Mucosa Digesta Mucosa Digesta
Treatments combined
Small intestine 0.001** 0.001** 0.001** 0.001**
Large intestine 0.001** 0.001** 0.001** 0.001**
All samples 0.001** 0.001** 0.001** 0.001**
AS700
Central jejunum 0.504 0.002** 0.001** 0.001**
Ileum 0.484 0.002** 0.028* 0.036*
Cecum 0.707 0.006** 0.571 0.007**
Descending colon 0.780 0.013* 0.002** 0.001**
Control
Central jejunum 0.363 0.144 0.001** 0.001**
Ileum 0.100 0.087 0.001** 0.001**
Cecum 0.433 0.040* 0.001** 0.001**
Descending colon 0.225 0.064 0.001** 0.001**
a All samples consisted of five replicate animals per treatment, with the
exception of digesta from the central jejunum of treatment cattle (n = 3), from
the ileum of control and AS700 treatment cattle (n = 3), and from the cecum
and descending colon of AS700 treated cattle (n = 4). The two p-values
presented per comparison reflect inter-group variability.
*Significant difference (P ≤ 0.05 and P > 0.01) between mucosa and digesta by
treatment/location for each of T-RF presence and T-RF relative abundance
(i.e. mucosa compared to digesta and visa-versa).
**Highly significant difference (P ≤ 0.01) between mucosa and digesta.
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(P ≤ 0.025) the number of T-RFs; in general, fewer T-RFs
(P ≤ 0.050) were observed in the small intestine relative
to the large intestine. Based on presence/absence of
T-RFs, bacterial community fingerprints associated with
mucosa differed (P ≤ 0.001) from those within digesta in
the small and large intestine (Table 2). Consistent with
the group significance test results, non-metric multidi-
mensional scaling (NMS) plots showed that bacterial
communities within digesta clustered separately from
communities associated with mucosa in the small
(Figure 2A) and large (Figure 3A) intestines. Differences
in community fingerprints associated with mucosa rela-
tive to digesta based on T-RF relative abundance were
also observed in the small and large intestine (P ≤ 0.001),
as well as for all individual locations (P ≤ 0.036) (Table 2).
Similarly, NMS plots showed that bacterial communities
within digesta clustered separately from communities
associated with mucosa (Figure 2B, 3B). It is important
to emphasize that different Qiagen kits were used to
extract genomic DNA from digesta versus mucosa.
Although these kits are both commonly used to extract
bacterial genomic DNA for community analyses, they
have never been comparatively evaluated to our know-
ledge. Thus, it is possible that the conspicuous differencesobserved in community composition between the two
substrates were influenced by the extraction method.
Administration of AS700 did not affect (P = 0.346)
numbers of T-RF associated with mucosa by sample
location. However, more (P = 0.034) T-RFs were ob-
served in digesta from cattle that ingested AS700 relative
to control treatment cattle (i.e. averaged across location)
(Table 1). With the exception of mucosa-associated
communities in the spiral colon (P = 0.047), AGP admin-
istration did not affect (P > 0.050) the community finger-
prints (based on T-RF presence/absence) associated with
mucosa or within digesta of the small and large intestine
(Table 3). Similarly, minimal differences between the
control and AS700 treatment were observed based on
T-RF relative abundance; however, mucosa-associated
communities in the proximal and central jejunum, and
cecum differed slightly (P < 0.03) between the two treat-
ments. Consistent with pairwise results, AS700 treat-
ment cattle community fingerprints did not cluster
separately from control treatment cattle in NMS plots
for both mucosa-associated (Figure 2A, 3A) and digesta
(Figure 2B, 3B) communities. Examination of T-RFs
Figure 2 Non-metric multi-dimensional scaling plots. Plots
depict community terminal restriction fragment (T-RF) presence/
absence (A) and T-RF relative abundance (B) within the small
intestine of control and AS700 treatment cattle. All locations consist
of five replicate animals, with the exception of digesta from the
distal jejunum for control treatment cattle (n = 3), and from the
ileum of control and AS700 treatment cattle (n = 3). Each marker
represents a bacterial community for one sample. Ellipsoids
represent predominant clustering of digesta relative to
mucosa-associated communities.
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AS700 treatment cattle within the small (56.6%, n = 107)
and large (64.1%, n = 132) intestine (Figure 4).
Quantitative PCR
Densities of total bacteria associated with mucosa or
within digesta did not differ between the AS700 and con-
trol treatments (P ≤ 0.66) (Figure 5A). However, differ-
ences in densities of mucosa-associated bacteria were
observed in the different regions of the intestine. Less
(P ≤ 0.026) bacteria were present in the small relative to
the large intestine. Within the small intestine, higher
densities (P ≤ 0.042) of bacteria occurred in the duodenum
than in the proximal small intestine. The highest densities
(P ≤ 0.035) of mucosa-associated bacteria occurred in the
cecum and rectum. Bacterial densities in digesta were 1.7
to 3.0 orders of magnitude larger (P < 0.001) than the cor-
responding mucosal samples (Figure 5A-B). Bacterial
numbers in digesta within the small intestine were smaller
(P < 0.001) than in the large intestine (Figure 5B). There
was no difference in bacterial densities within digesta in
the cecum or descending colon.
Clone library community analysis
Considerable bacterial diversity was associated with the mu-
cosa of the small and large intestine, as well as within
digesta of the descending colon of beef cattle (Table 4).
However, greater community richness and diversity were
observed in the large intestine relative to the small intestine.
Twice as many clones from the large intestine were
sequenced in comparison to the small intestine, yet the re-
stricted sampling within the small intestine better reflected
the diversity of operational taxonomic units (OTUs) associ-
ated with mucosa (Figure 6). The composition of the bacter-
ial community associated with mucosa of central jejunum
differed from that of the ileum, cecum and descending
colon (Figure 7); communities within the central jejunum
contained more Proteobacteria clones, specifically Ralstonia,
Bradyrhizobium, and Caulobacter, while the ileum, cecum
and descending colon were dominated by Firmicutes clones
(Figure 8; Additional file 1: Figure S1, Additional file 2:
Figure S2, Additional file 3: Figure S3, Additional file 4:
Figure S4). Lactobacillus, and unclassified Lachnospiraceae,
Ruminococcaceae and Peptostreptococccus clones were the
Figure 3 Non-metric multi-dimensional scaling plots. Plots depict
community terminal restriction fragment (T-RF) presence/absence
(A) and T-RF relative abundance (B) within the large intestine of control
and AS700 treatment cattle. All sections consist of five replicate animals,
with the exception of digesta from the cecum and descending colon
for cattle administered AS700 (n = 4). Each marker represents a bacterial
community for one sample. Ellipsoids represent predominant clustering
of digesta relative to mucosa-associated communities.
Table 3 Group significance pairwise comparisons of T-
RFLP bacterial community fingerprints associated with
mucosa or within digesta between beef cattle
administered (AS700) or not administered antimicrobial
growth promoters (Control)a
Sample/location T-RF presence/
absence
T-RF relative
abundance
AS700 Control AS700 Control
Digesta
Central jejunum 0.237 0.540 0.571 0.150
Ileum 0.718 0.140 0.588 0.169
Cecum 0.502 0.627 0.541 0.158
Descending colon 0.419 0.602 0.578 0.127
Mucosa
Duodenum 0.667 0.745 0.544 0.166
Proximal jejunum 0.852 0.269 0.335 0.030*
Central jejunum 0.872 0.062 0.919 0.009**
Distal jejunum 0.922 0.742 0.738 0.879
Ileum 0.324 0.409 0.321 0.066
Cecum 0.881 0.281 0.918 0.001**
Spiral colon 0.047* 0.462 0.468 0.062
Descending colon 0.959 0.167 0.954 0.350
Rectum 0.810 0.115 0.742 0.347
a All samples consisted of five replicate animals per treatment, with the
exception of digesta from the central jejunum of treatment cattle (n = 3), from
the ileum of control and AS700 treatment cattle (n = 3), and from the cecum
and descending colon of AS700 treated cattle (n = 4). The two p-values
presented per comparison reflect inter-group variability.
*Significant difference (P ≤ 0.05 and P > 0.01) between the AS700 and control
treatments by sample type/location for each of T-RF presence/absence and T-
RF relative abundance (i.e. AS700 compared to control and visa-versa).
**Highly significant difference (P ≤ 0.01) between the AS700 and control
treatments by sample type / location.
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Lachnospiraceae and Ruminococcaceae clones were the
most prevalent Firmicutes in the large intestine. Bacteria
within the phylum Bacteriodetes were less common in asso-
ciation with the mucosa in the ileum (0.6%) relative to the
large intestine (>20.9%). Numbers of predicted OTUs asso-
ciated with mucosa were 55, 59, 218, and 251 in the central
jejunum, ileum, cecum and descending colon, respectively,
and 248 from digesta within the colon (Table 4). In com-
parison, total T-RFs observed in the corresponding sam-
ples numbered 46.2 ± 8.2 (156 total), 54.8 ± 8.5 (142 total),
79.4 ± 12.1 (216 total), 87.4 ± 6.9 (267 total), and 68.4 ± 5.2
(247 total) T-RFs, respectively (Table 1). Richness, diver-
sity, and community composition of bacteria associated
with mucosa relative to within digesta did not differ within
the descending colon (Table 4; Figure 8; Additional file 4:
Figure S4, Additional file 5: Figure S5). This is consistent
with the observation of no difference in T-RF presence/
absence (Table 2; Figure 2–3).
Figure 4 Four-way Venn diagram. Unique and common T-RFs
among the small and large intestines of beef cattle not administered
(control treatment) and administered antimicrobial growth
promoters (AS700 treatment) are shown where: (A) small intestine of
control treatment cattle; (B) large intestine of control treatment
cattle; (C) small intestine of AS700 treatment cattle; and (D) large
intestine of AS700 treatment cattle.
Figure 5 Relative bacterial densities throughout the intestine
of beef cattle. Bacterial densities associated with mucosa (A) or
within digesta were measured in the small and large intestine of
beef cattle (log10 copy number μl-1 of template 16S rDNA).
Treatments are cattle administered AS700 (black histograms) and
cattle not administered antimicrobials (white histograms). Intestinal
locations are: (1) duodenum; (2) proximal jejunum; (3) central
jejunum; (4) distal jejunum; (5) ileum; (6) cecum; (7) spiral colon; (8)
descending colon; and (9) rectum. Vertical lines associated with
histograms indicate the standard error of the mean. Within A and B,
histogram bars at each location not followed by the same letter differ
(P < 0.05). Bars indicated by an asterisk differ (P < 0.001) between
digesta and mucosa-associated at corresponding locations.
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Although considerable effort has been expended charac-
terizing microbial communities in the rumen of cattle,
very limited research has focused on characterizing the
microbiota within the bovine intestine. In the current
study, we used T-RFLP in conjunction with qPCR and
clone library analyses to examine bacterial communities
associated with mucosa and within digesta throughout
the intestinal tract of beef cattle not previously exposed
to antimicrobials at any point in their lives. We observed
that community fingerprints differed along the intestinal
tract. In particular, greater T-RF diversity was observed
in the large intestine relative to small intestine. In mono-
gastric animals, both the microbial load and species
diversity significantly increase in the ileum and through-
out the colon [15].
Mucus secreted from goblet cells forms two distinct
layers in the gastrointestinal (GI)-tract [16]. These layers
vary in thickness throughout the intestine, and evidence
indicates that bacteria readily colonize the loosely adher-
ent mucus layer but not the adherent mucus layer [17].
The bacteria that colonize this mucus layer are likely im-
portant in maintaining host health [18,19]. We observed
that community fingerprints associated with mucosa dif-
fered from digesta in adjacent locations for all intestinal
locations sampled. This observation is consistent with a
recent finding in bovine calves using denaturing gradient
gel electrophoresis [20]. Almost all characterizations of
the intestinal microbiota of cattle utilizing molecular
methods to date have focused on the examination of fecal
matter [21-23]. However, the fecal microbiota is not ne-
cessarily representative of the intestinal microbiota [24].Fecal sampling is also limiting in that it does not allow an
examination of localized communities within the intestine
(i.e. autochthonous bacteria). This is further complicated
by the release of autochthonous bacteria from proximal
regions of the GI-tract, such as the rumen, that survive
transit.
To characterize the composition of the intestinal
microbiota of beef cattle, we completed traditional clone
analysis (near complete 16S rRNA gene sequence) of
composite samples obtained from the central jejunum,
ileum, cecum and descending colon; community finger-
prints of the samples were determined not to differ
significantly by T-RFLP analysis prior to pooling.
Proteobacteria clones were conspicuously more abun-
dant (53% of clones sequenced) in the jejunum com-
pared to the ileum (6.6%), cecum (2.3%), and descending
Table 4 Operational taxonomic units (OTUs) observed and community richness and diversity indices (97% DNA
sequence similarity)
Community richness Community diversity
Sample OTUs Chao ACE Shannon’s Non-parametric Shannon’s Simpson’s
Central jejunum mucosa [179]a 55 95 145 3.41 3.70 0.0455
(71–155)b (108–207)b (3.25-3.58)b (0.0349-0.0560)b
Ileum mucosa [181] 59 122 240 3.30 3.65 0.0766
(86-211) (184-320) (3.10-3.51) (0.0494-0.104)
Cecum mucosa [349] 218 430 533 5.17 5.80 0.00492
(355-548) (418-713) (5.07-5.27) (0.00335-0.00650)
Descending colon mucosa [368] 251 663 651 5.38 6.09 0.00287
(520–883) (521–842) (5.29-5.46) (0.00211-0.00364)
Descending colon digesta [367] 248 607 644 5.36 6.06 0.00305
(483–795) (517–833) (5.27-5.44) (0.00223-0.00388)
aValues in square brackets indicate number of clones.
bValues in parentheses indicate 95% confidence intervals.
Figure 6 Rarefaction curves. Rarefaction analysis was performed on: (A) mucosa-associated communities in the cecum (n = 349); (B) mucosa-
associated communities in the descending colon (n = 368); (C) communities within digesta in the descending colon (n = 367); (D) mucosa-
associated communities in the central jejunum (n=179); and (E) mucosa-associated communities in the ileum (n = 181).
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Figure 7 Phylum level classification. Classifications were determined using RDP classifier (16S rRNA gene sequences) for: (A) mucosa-associated
communities in the central jejunum (n = 179 total sequences); (B) mucosa-associated communities in the ileum (n = 181); (C) mucosa-associated
communities in the cecum (n = 349); (D) mucosa-associated communities in the descending colon (n = 368); (E) communities within digesta in
the descending colon (n = 367).
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[25], but to our knowledge the genera that we detected
are not recognized as abundant rumen constituents.
While the ileum contained bacterial clones that were
common to the jejunum as well as the cecum,
Firmicutes clones associated with mucosa dominated in
both the ileum (91.7%) and cecum (73.4%). Lactobacillus
and Streptococcus have been readily isolated throughout
the bovine intestinal tract [26,27]. Although we did not
detect any Streptococcus clones, we did detect Lactoba-
cillus clones at all sites with a particular predominance
in mucosa-associated samples within the ileum. The
cecum of monogastric animals is dominated by obligate
anaerobes, and it is currently unclear whether the ileal
microbiota represents a unique community or these
bacteria emanate from the cecum via leakage of cecal
bacteria through the ileocecal valve [15]. Although we
did not detect either Bacteroides or Prevotella clones in
the ileum as compared to the cecum, our data tended to
support a cecal origin given that common taxa and taxo-
nomic groups were observed in the ileum and the cecum,yet the richness and diversity of bacteria communities in
the ileum were much lower. Although bacteria in the
ileum likely originate from the cecum, their association
with with mucosa suggests that they are autochthonous
within the ileum. Despite its prominence, the nutritional
importance of the cattle cecum and its possible role as a
reservoir of enteric bacteria has not been fully determined.
An antimicrobial agent is a growth promoter when
administered at non-therapeutic concentrations in/on
the feed of food animals to promote growth and enhance
feed efficiency. Limited research has investigated the
impacts of these non-therapeutic concentrations of anti-
microbials on the enteric microbiota. Of note, chlor-
tetracycline and sulfamethazine administered at non-
therapeutic concentrations pass through the rumen of
cattle into the intestine, and are subsequently excreted
in feces [12,13]. Furthermore, a significant amount of
the chlortetracycline (administered as Aureo AS700 G)
is excreted in beef cattle feces in its non-isomerized
form [13], which is microbiologically active [28]. Selec-
tion for enteric pathogens and pathogen surrogates
Figure 8 Non-linear heat map of 16S rRNA gene clone frequencies. Frequencies are presented for: (A) mucosa-associated communities in
the central jejunum; (B) mucosa-associated communities in the ileum; (C) mucosa-associated communities in the cecum; (D) mucosa-associated
communities in the descending colon; and (E) communities within digesta in the descending colon. Clones were assigned to the following
phyla: (1) Acidobacteria; (2) Actinobacteria; (3) Bacteroidetes; (4) Firmicutes; (5) Lentisphaerae; (6) Planctomycetes; (7) Proteobacteria; (8)
Spirochaetes; and (9) Verrucomicrobia.
Reti et al. Gut Pathogens 2013, 5:8 Page 9 of 17
http://www.gutpathogens.com/content/5/1/8resistant to antimicrobials following administration of
AGPs has promulgated the belief that AGPs induce
growth promotion in livestock by their direct effects on
the intestinal microbiota (i.e. the microbiota modulation
hypothesis) [5,29]. To contrast intestinal bacterial com-
munities in cattle administered an AGP relative to con-
trol treatment animals, we used T-RFLP analysis. Data
showed that the oral administration of chlortetracycline
and sulfamethazine at non-therapeutic levels to cattlefor 193 days did not appreciably affect the intestinal
microbiota associated with mucosa or within digesta in
either the small or large intestine relative to cattle not
administered antimicrobials. T-RFLP is a medium- to
high-throughput comparative community fingerprinting
method and is recognized to provide both high resolution
and reproducible results [30] that are comparable to
pyrosequence-based analysis of communities [31]. The
T-RFLP method has been criticized by some as it does not
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the biological-relevance of rare occurring OTU is uncer-
tain, and T-RFLP analysis showed no significant impact of
AS700 on the predominant constituents of the intestinal
microbiota of beef cattle. Furthermore, the utilization of
T-RFLP analysis allowed us to process a large number of
samples (n = 122) without the high cost of next-generation
sequencing. This is particularly important in light of recent
evidence indicating that analysis of more samples at the
expense of sequence coverage is recommended [32], and
that a reliance on pseudo-replicates greatly increases the
chances of committing a type I statistical error [33].
Our results are in agreement with the conclusions of
Kalmokoff et al. [8] and McGarvey et al. [23], but contra-
dict those of Rettedal et al. [34], Looft et al. [35], and Kim
et al. [36]. Kalmokoff et al. [8], McGarvey et al. [23], and
Rettedal et al. [34] utilized clone library analysis, whereas
Looft et al. [35] and Kim et al. [36] used pyrosequence-
based analysis of bacterial communtities. Kalmokoff et al.
[8] showed that continuous administration of non-
therapeutic erythromycin to pigs did not affect fecal com-
munity structure, and McGarvey et al. [23] observed that
the administration of the ionophore, monensin, did not
alter the fecal microbiota in cattle. In contrast, Kim et al.
[36] concluded that tylosin phosphate administered to
pigs altered the composition of the bacterial community
in feces. Of note, pyrosequencing was used in this study,
but considerable inter-animal variability by farm and sam-
ple date was observed, thereby limiting the author’s ability
to definitively conclude that tylosin contributed to growth
promotion via modulation of the intestinal community.
Utilizing pyrosequence-based analysis, Looft et al. [35]
also concluded that chlortetracycline, sulfamethazine, and
penicillin administered to piglets at non-therapeutic con-
centrations for only 14 days altered the microbiota,
namely by increasing the prevalence of Proteobacteria.
However, they administered antimicrobials for a very short
duration, a small number of animals were examined once,
and analyses were restricted to feces. Furthermore,
Proteobacteria are not abundant constituents of the
colonic microbiota. Based on a critical review of the AGP
literature, Niewold [7] concluded that cumulative evidence
does not support the commonly held belief that AGPs pri-
marily function by modulating the intestinal microbiota. It
is recognized that many antimicrobials administered at
therapeutic concentrations are capable of altering immune
responses and bacterial communities within the intestine
[9,37]. However, Costa et al. [10] recently showed that
chlortetracycline administered to mice at non-therapeutic
concentrations modulated enteric inflammation in the
absence of conspicuous effects on the microbiota. It is
likely that the mode of action of AGPs is complex and
involves an interactive effect on the host and the intestinal
microbiota.Similarly to other species, a high degree of inter-
animal variability occurs in beef cattle [22]. Our experi-
mental design allowed us to treat animals identically
with the exception that AGP treatment cattle were ad-
ministered AS700 daily for 193 days (maximum
exposure model), whereas control treatment cattle were
not administered an AGP. A strength of our study is
that experimental units (i.e. individual animals) repre-
sented true replicates thereby allowing us to obtain a
measure of variability independent from treatment
effects. In this regard, treatment animals (100 beef
cattle) were placed in 10 separate pens, and one animal
was arbitrarily selected per pen and evaluated. Further-
more, cattle were maintained in an experimental feedlot
for ca. 8 months to replicate an actual production
scenario. However, the administration of AS700 ended
28 days before animals were euthanized and samples
were obtained (i.e. to meet mandatory withdrawal
requirements for AGPs). Thus, we are unable to defin-
itely ascertain whether the microbiota reverted to base-
line in the absence of selection pressure during the AGP
withdrawal period. This possibility appears unlikely
given that differential carriage of tetracycline and
sulfamethazine resistance determinants occurred in the
fecal bacterial community of AS700 versus control treat-
ment cattle, and carriage rates did not change after anti-
microbial administration halted (data not presented).
None-the-less, the impact of AGP withdrawal on intestinal
community structure and carriage of AGP resistant deter-
minants warrants investigation in subsequent research.
Materials and methods
Animals
Beef cattle were housed in an experimental feedlot located
at the Lethbridge Research Centre. Animals originated from
a common location and did not receive any antimicrobials
before the initiation of the experiment. Animals were arbi-
trarily assigned to one of two treatments: (i) no antimicro-
bials (control treatment) or (ii) 350 mg head-1 day-1
chlortetracycline and 350 mg head-1 day-1 sulfamethazine
(Aureo S 700 G; Alpharma Inc., NJ) [AS700 treatment].
Aureo S 700 G is a commonly used AGP for beef produc-
tion in North America [38], and was fed at a non-
therapeutic concentration as recommended by the manu-
facturer. Each treatment was replicated five times, and the
treatment groups were arranged in a complete randomized
design; each replicate consisted of a separate pen
containing ten steers. Water troughs were shared between
adjacent pens, but arranged in a manner so that only cattle
that received AS700 could drink from the same water
trough.
Before commencement of the study, the experiment
was approved by the Lethbridge Research Centre Animal
Care Committee, and all cattle involved in this study
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Canadian Council on Animal Care [39]. Steers entering
the feedlot November 29, 2004 were fed a forage based
diet consisting of 70% barley silage, 25% barley grain,
and 5% (dry matter basis) supplement with vitamins and
minerals for the first 84 days (i.e. ‘backgrounding’
period). Cattle were subsequently transitioned from the
predominately forage based diet to a predominantly
grain based diet over a 21 day period, and then
maintained on the grain based diet (85% barley, 10%
barley silage, 5% supplement) for an additional 126 days
(i.e. ‘finishing’ period); this feeding regimen is typical for
the Canadian feedlot industry. Cattle were fed once daily
in a manner that ensured that all feed that was allocated
to each pen was consumed. AS700 was first introduced
into the diets 5 days after the cattle arrived at the feed-
lot, and it was included in the diet for 193 days there-
after; AS700 was removed from the diet 28 days prior to
slaughter to meet the requisite withdrawal period. To
avoid cross contamination, antimicrobials were mixed
with 5 kg of a supplement containing minerals and vita-
mins, and the mixture was manually spread over the
surface of feed in each of the appropriate pens; all cattle
in the pen were capable of feeding at the feed trough at
the same time. Supplement that did not contain any
antimicrobials was spread on the feed of cattle assigned
to the control treatment.
Sample collection
Fecal samples were obtained from cattle upon arrival at
the feedlot and at intervals thereafter (total of nine sam-
ple times over a 226-day period). To obtain samples,
individual cattle were placed in constraint device, and
fecal samples were extracted per rectum. Care was taken
to ensure that animals did not cross contaminate each
other across treatments. Fecal samples were immediately
placed on ice, and within 1 h of collection samples were
transported to the laboratory and stored at −20°C until
processed.
For mucosa and digesta samples, one animal per repli-
cate from each of the control and AS700 treatment was
randomly selected for sampling in the abattoir (n = 5
cattle per treatment); the abattoir used was a provincially
inspected medium capacity plant. Cattle were transported
to the abattoir on the evening prior to euthanization. Con-
trol treatment cattle were transported on July 17, 2005
and slaughtered the next day, whereas AS700 cattle were
transported July 18, 2005 and also slaughtered the next
day. Following transport of the control treatment cattle,
the stock trailer was thoroughly cleaned using a pressure
washer. At the abattoir, cattle were maintained on a barley
silage diet, and were euthanized humanely according to
the Canadian Council on Animal Care [39]. The intestinal
tract of individual cattle was removed ≈ 10 min aftereuthanization, and placed on a clean sheet of plastic on a
cool cement floor within the abattoir. Nine intestinal
sections (≈20-cm long) were obtained from each animal at
the following locations: descending portion of the duode-
num (i.e. following the cranial flexure); proximal jejunum;
central jejunum; distal jejunum; ileum (≈10 cm before the
ileal-cecal junction); free end of the cecum; spiral colon
(i.e. central flexure of the ascending colon); descending
colon (≈20 cm before the sigmoid colon); and rectum. Be-
fore excision of the intestinal sections, bilateral ligatures
were applied adjacent to the excision site to minimize ex-
ternal contamination of the tissues with digesta. Tissue
samples were then placed in individual bags on ice and
transported to the laboratory for processing.
Mucosa and digesta within the intestinal lumen were
sampled. Intestinal sections were aseptically excised lon-
gitudinally and digesta removed aseptically. Digesta from
each sample was weighed (200 mg ± 20 mg) and placed
in DNA free tubes. Following removal of the majority of
digesta, the mucosal surface within each intestinal
section was gently washed with chilled sterile phosphate
buffer with saline (PBS; 10 mM sodium phosphate buffer
with 130 mM sodium chloride; pH 7.2) taking care to
remove residual digesta while minimizing disruption of
mucus on the mucosal surface. Mucosal sections were
removed with a sterile 4-mm diameter Biopsy Acu
Punch (CDMV, St. Hyacinthe, QC) and individual plugs
were placed in DNA free tubes. Digesta and mucosal
plugs were stored at −20°C until processed.
Genomic DNA extraction
Total genomic DNA was extracted from mucosal plugs
using the protocol for Gram positive bacteria of the
DNeasy Blood and Tissue Kit (Qiagen, Inc., Toronto,
ON), and from feces and digesta samples (200 ± 5 mg)
using the QIAamp DNA Stool Mini Kit (Qiagen, Inc.).
Both protocols were conducted according to the manu-
facturer’s recommendations. Concentrations of genomic
DNA from all samples were verified by electrophoresis
in a 1% TAE agarose gel.
T-RFLP community analysis
DNA encoding the 16S rRNA gene was amplified by
PCR [40]. Each reaction consisted of 2 μl of genomic
DNA (≈10 ng), 2.0 μl of 1X PCR buffer, 0.1 μl of each
deoxynucleoside triphosphate (0.2 mM), 2.0 μl of acety-
lated bovine serum albumin (BSA; Promega, Madison,
WI; 0.1 μg μl-1), 0.1 μl of Taq DNA polymerase (Qiagen,
Inc.; 5 units μl-1), 1.0 μl each of the bacterial primers
27F-labeled with 6-fam and 1492R (0.5 μM) [41], and
11.5 μl Optima water (Fisher Scientific, Ottawa, ON).
PCR conditions were 95°C for 15 min; 34 cycles
consisting of 94°C for 30 s, 53°C for 90 sec, and 72°C for
1 min; and a final extension period at 72°C for 10 min.
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pooled. All amplicons were electrophoresed in a 1% TAE
agarose gel relative to a 100 bp DNA ladder (Promega).
A single amplicon of ≈ 1500 base pairs was observed in
most samples, and these amplicons were purified using
QIAquick PCR purification Kit (Qiagen, Inc.). For some
mucosal samples, non-specific amplification was observed,
and in such cases, the target amplicon was recovered from
1% TAE agarose using QIAquick Gel Extraction Kit
(Qiagen, Inc.). DNA concentrations were quantified using
a TD 360 Mini Fluorometer (Turner Designs, Sunnyvale,
CA) using TNE buffer / Hoescht dye. If required, DNA
concentrations were also quantified by agarose gel electro-
phoresis. Concentrations of DNA in all samples were stan-
dardized to 25 ng μl-1 using Optima water.
Restriction digests were carried out in duplicate in a
mixture containing 75 ng of the purified PCR product, 3
units of HaeIII (Invitrogen Canada Inc., Burlington,
ON), 2.5 μl of enzyme buffer, and Optima water to a
final volume of 25 μl. Samples were incubated at 37°C
for 2 h in the dark, and ethanol precipitation was
performed to stop the reaction by adding 50 μl of 95%
ethanol and 2 μl of sodium acetate (pH 5.2) to each
sample. Samples were incubated for 20 min at 20°C, and
centrifuged for 20 min (13,200 × g) to pellet DNA.
Nucleic acids were washed by adding 500 μl of 70% etha-
nol, followed by centrifugation at 13,200 × g for 5 min.
After ethanol precipitation, samples were air dried
overnight in the dark, re-suspended in 9.25 μl of Hi Di
formamide (Applied Biosystems Canada, Streetsville,
ON) and 0.25 μl of LIZ600 size standard marker (Ap-
plied Biosystems Canada, Streetsville, ON), denatured at
95°C for 3 min, and immediately placed on ice. Fluores-
cent labeled terminal restriction fragments (T-RFs) were
separated in POP7 polymer using a 3130 Genetic
Analyzer (Applied Biosystems Canada), and analyses
were performed on T-RFs ranging in size from 50 to 580
base pairs covering V1 to V3 of the 16S rRNA gene.
Two electropherograms were obtained per sample (i.e.
separate runs), and each electropherogram was analyzed
separately using GeneMapper software version 4.0 with
the Local Southern size calling method (Applied
Biosystems Canada).
A tabulated raw data file from GeneMapper was
uploaded to T-RFLP Analysis Expedited (T-REX) [42].
Using T-RF peak height, ‘true’ peaks were distinguished
from background fluctuations in fluorescence using a
standard deviation of three [43]. Only T-RFs that were
common to both electropherograms were used in ana-
lyses. T-RFs were then aligned using a clustering method
[44] and a clustering threshold of 0.5 base pairs (bp).
Two separate data matrices were constructed for down-
stream analyses; one matrix for T-RF presence/absence
and one matrix using T-RF relative abundance data. Thedata matrices were imported to Bionumerics software
version 5.1 (Applied Maths Inc., Austin, TX) for cluster
and genetic similarity analyses [40]. Cluster analysis was
performed on the T-RF presence/absence data using the
Dice coefficient and on T-RF relative abundance data
using Bray Curtis. The statistical significance of each
group was tested by grouping the treatment replicates
within each intestinal location, and comparing the within
and between group similarities with randomization tests
using 1000 iterations (Applied Maths Inc.) [40]. A prob-
ability level of ≤0.05 was used to distinguish distinct
groups in a two way comparison (i.e. group A compared
to group B and visa-versa). To further explore similarities
or dissimilarities in data, non-metric multi-dimensional
scaling (NMS) was applied using SAS (SAS Institute Inc.,
Cary, NC) and three dimensional NMS plots were
graphed using SigmaPlot (Systat Software Inc., Chicago,
IL). To determine the number of shared and unique
OTUs, Venn diagrams were constructed using the T-RF
presence/absence data matrix from T-REX. Analysis of
variance (ANOVA) for occurrence of T-RFs was
performed as a completely randomized design, using the
MIXED procedure of SAS (SAS Institute Inc.), with loca-
tion, treatment, and their interaction included in the
model as fixed effects. The repeated measurement state-
ment was applied given sample locations were correlated
within animal, and the proper error structure was deter-
mined using Akaike’s information criterion and the Bayesian
information criterion. Least squares were generated for
significant effects and Fisher's protected least signifi-
cant difference test was used to compare differences
among means of interest.
Clone library community analysis
Clone libraries were constructed from control treatment
cattle given that the analysis of T-RFLP fingerprints indi-
cated that communities in the intestines of cattle adminis-
tered AS700 did not differ appreciably from those in
control treatment cattle. Clone libraries were constructed
in duplicate (i.e. to minimize potential PCR bias) from
DNA isolated from mucosa from the central jejunum, mu-
cosa from the ileum, mucosa from the cecum, mucosa
from the descending colon, and digesta from the descend-
ing colon. As T-RFLP analyses indicated that community
fingerprints were relatively consistent across replicate ani-
mals, DNA from all five animals was combined in equal
concentrations into a composite mixture and collective
libraries were constructed and analyzed.
DNA encoding the 16S rRNA gene was amplified by
PCR using bacterial primers as described above except
that unlabeled 27F was used. PCR conditions were:
95°C for 15 min; 25 (digesta), 30 (mucosa from the
ileum, cecum and descending colon), or 35 (mucosa
from the central jejunum) cycles consisting of 94°C for
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extension period at 72°C for 10 min. In an attempt to
minimize PCR bias, the fewest PCR cycles possible
were used.
Traditional clone libraries were constructed using the
pGEMW T Easy Vector system with JM109 competent
cells (Promega). For ligation, 3 μl of the PCR product
and the manufacturers’ reagents for a "standard reaction"
were incubated overnight at 4°C. The entire ligation
product was then added to 100 μl of the competent cells
which were transformed chemically following instruc-
tions of the manufacturer with the exception that
β-mercaptoethanol was not used. The transformation
mixture was plated on 200 ml Luria Burtani (LB) agar
containing 10 mg ml-1 filter sterilized ampicillin (amp).
To induce color differentiation, 320 μl X-Gal in
dimethylformamide (50 mg ml-1) and 100 μl of 10 mM
Isopropyl β-D-1 thiogalactopyranoside were added to
the agar. Escherichia coli cultures were incubated over-
night at 37°C.
Colonies potentially containing a 16S rRNA insert (i.e.
white colonies) were picked using a QPIX robot
(Genetix Ltd, San Jose, CA) and prepared for Sanger se-
quencing. Picked colonies were first grown overnight at
37°C in 150 μl of LB amp (100 μg ml-1) freezing medium
and colony PCR was subsequently performed to ascer-
tain the presence of an insert. Each reaction consisted
of 1 μl of E. coli cells, 2.0 μl of 1X PCR buffer, 0.1 μl of
each deoxynucleoside triphosphate (0.2 mM), 2.0 μl of
BSA (0.1 μg μl-1), 0.1 μl of Taq DNA polymerase (5 units
μl-1; Qiagen, Inc.), 1.0 μl each of M13 Forward and M13
Reverse primers, and 12.5 μl of Optima water. PCR con-
ditions were: 95°C for 15 min; 35 cycles at 95°C for
30 sec, 54°C for 45 sec, and 72°C for 90 sec; and a final
extension period at 72°C for 6 min. To ensure that the
PCR product contained 16S rDNA, gel electrophoresis
(1% TAE agarose) was performed.
Sanger sequencing was performed on 192 16S rDNA
clones each from the central jejunal and ileal mucosa, 384
clones each from the cecal and descending colonic mu-
cosa, and 384 clones from digesta within the descending
colon. The PCR product was purified using the MiniElute
96 UF PCR Purification Kit (Qiagen, Inc.). A wash step
was performed to increase purity of the DNA, and the
recovery of the eluate was completed with 30 μl of Optima
water. Sanger sequencing was conducted by Macrogen
Corporation (Rockville, MD) using an ABI3730XL
machine (Applied Biosystems, Foster City, CA) and the
primers 27F and 1492R [41].
Geneious (Biomatters Ltd, Auckland, New Zealand)
was used to assemble contigs, and examine electrophe-
rograms to ensure proper base calling. Low quality se-
quences were excluded from further analyses. Sequences
were aligned with the GreenGenes NAST alignment tool[45] and putative chimeras were detected using Mallard
[46] and the GreenGenes chimera check [47]. Putative
chimeras were confirmed with Pintail [48], and were ex-
cluded from subsequent analyses. S-Libshuff web [49]
was used to ensure that there was not a significant differ-
ence between replicate libraries (P > 0.05). Replicate librar-
ies were combined, and Mothur was used to construct
rarefaction curves, define OTUs, and estimate community
richness (i.e. Chao1 and ACE estimators) and community
diversity (i.e. Shannon, non-parametric Shannon and
Simpson indices) for each library [50]. Near full length
16S rRNA clone sequences (831 clones in total), and refer-
ence sequences and cloned sequences for each library
were aligned using the GreenGenes NAST alignment [45],
and trees were subsequently constructed in Geneious
(Biomatters Ltd); reference sequences (i.e. best type strain
match) were obtained from the SEQ Match function of
the Ribosomal Database Project (RDP; http://rdp.cme.
msu.edu/). Sequence data for the manual construction of
a non-linear heat map and taxon frequency pie graphs
were obtained using RDP Classifier. The sequence data
were accessioned in the GenBank database under the
numbers: JX095670 to JX095848 for the middle jejunum
(mucosa-associated); JX095849 to JX096028 for the
ileum (mucosa-associated); JX094956 to JX095303 for the
cecum (mucosa-associated); JX096029 to JX096391 for
the descending colon (mucosa-associated); and JX095304
to JX095669 for the descending colon (digesta).
Quantitative PCR
To quantify total bacteria, genomic DNA extracted from
mucosa and digesta was subjected qPCR for total
bacteria using the primers, HDA1 and HDA2 [51]; these
primers were evaluated by SPYDER in silico and were
found to detect ≈ 88% of bacterial 16S rDNA sequences
within the RDP database [52]. Each reaction consisted of
10 μl of 2X QuantiTect SYBR Green (Qiagen, Inc.),
1.8 μl of HDA1 (10 μM), 1.2 μl of HDA2 (10 μM), 2.0 μl
of BSA (1 mg ml-1), 3 μl of nuclease free water (Qiagen,
Inc.), and 2 μl of template. Samples were amplified and
fluorescence was detected on an Mx3005P thermocycler
(Agilent Technologies Inc.). Thermocycler conditions
consisted of an activation cycle of 95°C for 15 min,
followed by 40 cycles at 94°C for 15 sec, 56°C for 30 sec,
and 72°C for 30 sec; qPCR reaction conditions were
optimized with DNA from E. coli (ATCC 25922). Copy
numbers of the 16S rRNA gene in extracted genomic
DNA were interpolated from a standard curve of
genomic DNA from E. coli (ATCC 25922) with 1 ng of
E. coli DNA containing 1.4 × 106 genome copies [53].
For analysis of variance, copy number was log10
transformed to normalize variance and data were ana-
lyzed using the mixed procedure of SAS (SAS Institute
Inc, Cary NC). Treatment and time or location and their
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fixed effects. The repeated measurement statement was
applied given that mucosal and digesta samples collected
at different locations were correlated within animal. The
appropriate error structure was determined using Akaike’s
information criterion and the Bayesian information criter-
ion, and the univariate procedure (SAS Institute, Inc.) was
used to produce normal probability plots to confirm
normality. Least squares were generated for significant
effects and Fisher's protected least significant difference
test was used to compare differences between treatments
and locations.Additional files
Additional file 1: Figure S1. Unrooted phylogenetic tree of mucosa-
associated bacteria within the central jejunum of beef cattle not
administered antimicrobials (179 clones) and closest reference bacteria
(NCBI Accession Number in parentheses) where: 1 =Oscillibacter
valericigenes (AB238598); 2 = Acetivibrio cellulolyticus (L35516); 3 = Clostridium
colicanis (AJ420008); 4 = Clostridium disporicum (Y18176); 5 = Clostridium
irregulare (X73447); 6 = Lactobacillus amylovorus (AY944408); 7 = Lactobacillus
mucosae (AF126738); 8 = Syntrophococcus sucromutans (AF202264);
9 = Phascolarctobacterium faecium (X72865); 10 =Mycobacterium
aubagnense (AY859683); 11 = Propionibacterium acnes (AB042288);
12 = Knoellia aerolata (EF553529); 13 = Bifidobacterium saeculare (D89328);
14 = Campylobacter jejuni (DQ174144); 15 = Campylobacter coli (AF372092);
16 = Helicobacter canadensis (AF262037); 17 = Sediminibacterium salmoneum
(EF407879); 18 = Ferruginibacter lapsinanis (FJ177532); 19 = Ferruginibacter
alkalilentus (FJ177530); 20 = Prevotella copri (AB064923); 21 = Sorangium
cellulosum (EU240497); 22 = Desulfuromonas acetexigens (U23140);
23 = Steroidobacter denitrificans (EF605262); 24 = Nevskia soli (EF178286);
25 = Ralstonia pickettii (AY741342); 26 = Ralstonia insidiosa (AF488779);
27 = Janthinobacterium lividum (Y08846); 28 =Delftia tsuruhatensis
(AB075017); 29 = Shigella flexneri (X96963); 30 = Enterobacter asburiae
(AB004744); 31 =Magnetospirillum magnetotacticum (Y10110);
32 = Hyphomicrobium facile (Y14309); 33 =Mesorhizobium pluifarium
(Y14158); 34 = Caulobacter segnis (AB023427); 35 = Caulobacter henriccii
(AJ227758); 36 = Caulobacter mirabilis (AJ227774); 37 = Phenylobacterium
lituiforme (AY534887); 38 = Phenylobacterium immobile (Y18216);
39 = Bradyrhizobium yuanmingense (AF193818); 40 = Bradyrhizobium
pachyrhizi (AY624135); 41 = Bradyrhizobium betae (AY372184); and
42 = Bradyrhizobium liaoningense (AF208513).
Additional file 2: Figure S2. Unrooted phylogenetic tree of mucosa-
associated bacteria within the ileum of beef cattle not administered
antimicrobials (181 clones) and closest reference bacteria (NCBI Accession
Number in parentheses) where: 1 = Clostridium irregulare (X73447);
2 = Thermotalea metallivorans (EU443727); 3 = Anaerovorax odorimutans
(AJ251215); 4 =Mogibacterium vescum (AB021702); 5 = Bulleidia extructa
(AF220064); 6 = Clostridium celatum (X77844); 7 = Clostridium disporicum
(Y18176); 8 = Clostridium colicanis (AJ420008); 9 = Desulfitobacterium
metallireducens (AF297871); 10 = Anaerovibrio lipolyticus (AB034191);
11 = Turicibacter sanguinis (AF349724); 12 = Lactobacillus curvatus
(AM113777); 13 = Lactobacillus mucosae (AF126738); 14 = Lactobacillus
amylovorus (AY944408); 15 = Lactobacillus ruminis (AB326354);
16 = Hydrogenoanaerobacterium saccharovorans (EU158190);
17 = Oscillibacter valericigenes (AB238598); 18 = Eubacterium plautii
(AY724678); 19 = Papillibacter cinnamivorans (AF167711);
20 = Bifidobacterium saeculare (D89328); 21 = Barnesiella intestinihominis
(AB370251); 22 = Shigella flexneri (X96963); 23 = Escherichia fergusonii
(AF530475); 24 = Campylobacter jejuni (DQ174144); 25 = Campylobacter
curvus (DQ174165); 26 = Clostridium sufflavum (AB267266); 27 = Acetivibrio
celluloyticus (L35516); 28 = Clostridium clariflavum (AB186359);
29 = Syntrophococcus sucromutans (AF202264); 30 = Blautia wexlerae
(EF036467); 31 = Blautia luti (AJ133124); 32 = Blautia hydrogenotrophica(X95624); 33 = Coprococcus comes (EF031542); 34 = Hespellia stercorisuis
(AF445264); 35 = Coprococcus catus (AB038359); 36 = Roseburia
inulinivorans (AJ270473); and 37 = Clostridium aldenense (DQ279736).
Additional file 3: Figure S3. Unrooted phylogenetic tree of mucosa-
associated bacteria within the cecum of beef cattle not administered
antimicrobials (349 clones) and closest reference bacteria (NCBI Accession
Number in parentheses) where: 1 = Parabacteroides goldsteinii (AY974070);
2 = Barnesiella viscericola (AB267809); 3 = Barnesiella intestinihominis
(AB370251); 4 = Paraprevotella clara (AB331896); 5 = Bacteroides plebeius
(AB200217); 6 = Bacteroides coprocola (AB200224); 7 = Bacteroides
massiliensis (AY126616); 8 = Prevotella histicola (EU126661); 9 = Alistipes
onderdonkii (AY974071); 10 = Alistipes finegoldii (AY643083); 11 = Rikenella
microfusus (L16498); 12 = Pedobacter hartonius (AM491371); 13 =
Pedobacter cryoconitis (AJ438170); 14 = Sediminibacterium salmoneum
(EF407879); 15 = Treponema porcinum (AY518274); 16 = Victivallis vadensis
(AY049713); 17 = Akkermansia muciniphila (AY271254); 18 =
Planktothricoides raciborskii (AB045960); 19 = Acidobacterium capsulatum
(CP001472); 20 = Steroidobacter denitrificans (EF605262); 21 = Aeromonas
salmonicida (X60407); 22 = Aeromonas jandaei (X60413); 23 =
Ruminobacter amylophilus (Y15992); 24 = Pseudolabrys taiwanensis
(DQ062742); 25 = Caulobacter henricii (AJ227758); 26 = Clostridium
irregulare (X73447); 27 = Thermotalea metallivorans (EU443727); 28 =
Anaerovorax odorimutans (AJ251215); 29 = Eubacterium infirmum (U13039);
30 = Clostridium disporicum (Y18176); 31 = Clostridium chartatabidum
(X71850); 32 = Lactobacillus mucosae (AF126738); 33 = Lactobacillus
amylovorus (AY944408); 34 = Lactobacillus ruminis (AB326354); 35 = Bacillus
humi (AJ627210); 36 = Eubacterium callanderi (X96961); 37 =
Desulfosporosinus lacus (AJ582757); 38 = Desulfitobacterium metallireducens
(AF297871); 39 = Desulfitibacter alkalitolerans (AY538171); 40 = Clostridium
clariflavum (AB186359); 41 = Acetivibrio cellulolyticus (L35516); 42 =
Clostridium sufflavum (AB267266); 43 = Clostridium caenicola (AB221372);
44 = Ethanoligenens harbinense (AY295777); 45 = Clostridium cellulosi
(L09177); 46 = Acetanaerobacterium elongatum (AY487928); 47 =
Hydrogenoaerobacterium saccharovorans (EU158190); 48 = Anaerotruncus
colihominis (AJ315980); 49 = Ruminococcus albus (L76598); 50 =
Ruminococcus bromii (L76600); 51 = Faecalibacterium prausnitzii (AJ41395);
52 = Butyricicoccus pullicaecorum (EU410376); 53 = Oscillibacter
valericigenes (AB238598); 54 = Eubacterium plautii (AY724678); 55 =
Papillibacter cinnamivorans (AF167711); 56 = Lutispora thermophila
(AB186360); 57 = Gracilibacter thermotolerans (DQ117465); 58 = Clostridium
jejuense (AY494606); 59 = Anaerosporobacter mobilis (AY534872); 60 =
Robinsoniella peoriensis (AF445285); 61 = Hespellia porcina (AF445239);
62 = Ruminococcus lactaris (L76602); 63 = Coprococcus comes (EF031542);
64 = Coprococcus eutactus (EF031543); 65 = Blautia schinkii (X94965); 66 =
Blautia luti (AJ133124); 67 = Blautia hydrogenotrophica (X95624); 68 =
Roseburia intestinalis (AJ312385); 69 = Roseburia faecis (AY305310); 70 =
Coprococcus catus (AB038359); 71 = Clostridium lavalense (EF564277); 72 =
Clostridium aldenense (DQ279736); 73 = Syntrophococcus sucromutans
(AF202264); 74 = Pseudobutryrivibrio ruminis (X95893); 75 =
Parasporobacterium paucivorans (AJ272036); 76 =Megasphaera
micronuciformis (AF473834); 77 = Phascolarctobacterium faecium (X72865);
and 78 = Anaerovibrio lipolyticus (AB034191).
Additional file 4: Figure S4. Unrooted phylogenetic tree of mucosa-
associated bacteria within the descending colon of beef cattle not
administered antimicrobials (368 clones) and closest reference bacteria
(NCBI Accession Number in parentheses) where: 1 = Oscillibacter
valericigenes (AB238598); 2 = Eubacterium plautii (AY724678); 3 =
Sporobacter termitidis (Z49863); 4 = Papillibacter cinnamivorans (AF167711);
5 = Butyricicoccus pullicaecorum (EU410376); 6 = Ethanoligenens harbinense
(AY295777); 7 = Clostridium cellulosi (L09177); 8 = Acetanaerobacterium
elongatum (AY487928); 9 = Hydrogenoanaerobacterium saccharovorans
(EU158190); 10 = Anaerotruncus colihominis (AJ315980); 11 = Ruminococcus
albus (L76598); 12 = Ruminococcus flavefaciens (L76603); 13 = Clostridium
sporosphaeroides (X66002); 14 = Ruminococcus bromii (L76600); 15 =
Clostridium caenicola (AB221372); 16 = Clostridium clariflavum (AB186359);
17 = Acetivibrio cellulolyticus (L35516); 18 =Macrococcus brunensis
(AY119686); 19 = Bacillus funiculus (AB049195); 20 = Vulcanibacillus
modesticaldus (AM050346); 21 = Lactobacillus amylovorus (AY944408);
22 = Eubacterium tortuosum (L34683); 23 = Erysipelothrix inopinata
(AJ550617); 24 = Turicibacter sanguinis (AF349724); 25 = Acholeplasma
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http://www.gutpathogens.com/content/5/1/8axanthum (AF412968); 26 = Desulfosporosinus lacus (AJ582757); 27 =
Desulfitobacterium metallireducens (AF297871); 28 = Thermincola
ferriacetica (AY631277); 29 = Anaerovibrio lipolyticus (AB034191); 30 =
Phascolarctobacterium faecium (X72865); 31 = Dietzia maris (X79290); 32 =
Rubrobacter taiwanensis (AF465803); 33 = Akkermansia muciniphila
(AY271254); 34 = Rhodopirellula baltica (BX294149); 35 = Tistrella mobilis
(AB071665); 36 = Roseburia intestinalis (AJ312385); 37 = Roseburia faecis
(AY305310); 38 = Roseburia inulinivorans (AJ270473); 39 = Lachnobacterium
bovis (AF298663); 40 = Blautia luti (AJ133124); 41 = Blautia
hydrogenotrophica (X95624); 42 = Coprococcus catus (AB038359); 43 =
Anaerosporobacter mobilis (AY534872); 44 = Ruminococcus lactaris
(L76602); 45 = Ruminococcus gauvreauii (EF529620); 46 = Robinsoniella
peoriensis (AF445285); 47 = Hespellia porcina (AF445239); 48 = Dorea
longicatena (AJ132842); 49 = Coprococcus eutactus (EF031543); 50 =
Coprococcus comes (EF031542); 51 = Clostridium jejuense (AY494606); 52 =
Catonella morbi (X87151); 53 = Clostridium irregulare (X73447); 54 =
Eubacterium sulci (AJ006963); 55 = Anaerovorax odorimutans (AJ251215);
56 = Thermotalea metallivorans (EU443727); 57 = Soehngenia saccharolytica
(AY353956); 58 = Clostridium disporicum (Y18176); 59 = Clostridium
butyricum (AJ458420); 60 = Clostridium puniceum (X71857);
61 = Paraprevotella xylaniphila (AB331897); 62 = Paraprevotella clara
(AB331896); 63 = Prevotella salivae (AB108826); 64 = Prevotella nanceiensis
(AY957555); 65 = Bacteroides plebeius (AB200217); 66 = Bacteroides
coprocola (AB200224); 67 = Bacteroides massiliensis (AY126616); 68 =
Bacteroides gallinarum (AB253732); 69 = Paludibacter propionicigenes
(AB078842); 70 = Petrimonas sulfuriphila (AY570690); 71 = Barnesiella
viscericola (AB267809); 72 = Barnesiella intestinihominis (AB370251); 73 =
Alistipes shahii (AY974072); 74 = Alistipes finegoldii (AY643083); 75 =
Alistipes onderdonkii (AY974071); 76 = Rikenella microfusus (L16498); 77 =
Pedobacter cryoconitis (AJ438170); 78 = Lutispora thermophila (AB186360);
79 = Gracilibacter thermotolerans (DQ117465); and 80 = Natronovigra
wadinatrunensis (EU338489).
Additional file 5: Figure S5. Unrooted phylogenetic tree of bacteria in
digesta within the descending colon of beef cattle not administered
antimicrobials (367 clones) and closest reference bacteria (NCBI Accession
Number in parentheses) where: 1 = Alistipes onderdonkii (AY974071); 2 =
Alistipes finegoldii (AY643083); 3 = Rikenella microfusus (L16498); 4 =
Bacteroides plebeius (AB200217); 5 = Bacteroides coprocola (AB200224); 6 =
Bacteroides massiliensis (AY126616); 7 = Bacteroides gallinarum (AB253732);
8 = Paraprevotella xylaniphila (AB331897); 9 = Paraprevotella clara
(AB331896); 10 = Prevotella copri (AB064923); 11 = Prevotella nanceiensis
(AY957555); 12 = Barnesiella viscericola (AB267809); 13 = Barnesiella
intestinihominis (AB370251); 14 = Parabacteroides merdae (AB238928); 15 =
Paludibacter propionicigenes (AB078842); 16 = Pedobacter cryoconitis
(AJ438170); 17 = Phascolarctobacterium faecium (X72865); 18 =
Propionispira arboris (Y18190); 19 = Lutispora thermophila (AB186360); 20 =
Gracilibacter thermotolerans (DQ117465); 21 = Natronovirga
wadinatrunensis (EU338489); 22 = Caloramator australicus (EU409943);
23 = Clostridium clariflavum (AB186359); 24 = Acetivibrio cellulolyticus
(L35516); 25 = Sporobacter termitidis (Z49863); 26 = Papillibacter
cinnamivorans (AF167711); 27 = Eubacterium plautii (AY724678); 28 =
Oscillibacter valericigenes (AB238598); 29 = Butyricicoccus pullicaecorum
(EU410376); 30 = Clostridium sporospaeroides (X66002); 31 = Ruminococcus
bromii (L76600); 32 = Ethanoligenens harbinense (AY295777); 33 =
Clostridium cellulosi (L09177); 34 = Acetanaerobacterium elongatum
(AY487928); 35 = Hydrogenoanaerobacterium saccharovorans (EU158190);
36 = Anaerotruncus colihominis (AJ315980); 37 = Ruminococcus albus
(L76598); 38 = Ruminococcus flavefaciens (L76603); 39 = Desulfonispora
thiosulfatigenes (Y18214); 40 = Desulfitobacterium metallireducens
(AF297871); 41 = Desulfitobacterium chloroespirans (U68528); 42 =
Desulfosporosinus auripigmenti (AJ493051); 43 = Clostridium irregulare
(X73447); 44 = Thermotalea metallivorans (EU443727); 45 = Eubacterium
sulci (AJ006963); 46 = Anaerovorax odorimutans (AJ251215); 47 =
Clostridium saccharoperbutylacetonicum (U16122); 48 = Treponema
porcinum (AY518274); 49 = Succinivibrio dextrinosolvens (Y17600); 50 =
Acholeplasma axanthum (AF412968); 51 = Ruminococcus gauvreauii
(EF529620); 52 = Robinsoniella peroriensis (AF445285); 53 = Clostridium
citroniae (DQ279737); 54 = Roseburia intestinalis (AJ312385); 55 = Roseburia
faecis (AY305310); 56 = Lachnobacterium bovis (AF298663); 57 =
Pseudobutyrivibrio ruminis (X95893); 58 = Coprococcus comes (EF031542);59 = Ruminococcus lactaris (L76602); 60 = Dorea longicatena (AJ132842);
61 = Clostridium phytofermentans (CP000885); 62 = Anaerosporobacter
mobilis (AY534872); 63 = Hyphomicrobium zavarzinii (Y14305); 64 =
Prochlorococcus marinus (AE017126); 65 = Planktothricoides raciborskii
(AB045960); and 66 = Akkermansia muciniphila (AY271254).Competing interests
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